The FDA has called a plan to publish certain complete response letters (CRLs) for medicines it has rejected after an initial ...

It is the second licensing deal that AbbVie has negotiated this year for a trispecific for multiple myeloma, coming in the ...

From robot-assisted surgery to personalised disease treatment - technology can do some truly remarkable things. But while the ...

Technology has also improved immunisation operations with the use of online appointment scheduling that automates ...

The acquisition – which will see MSD pay $107 for each American Depository Share (ADS) in UK-headquartered Verona – is the ...

So, what were the major themes to come out of BIO Boston 2025? Who’s getting excited about what? And – besides the obvious ...

Toymaker Mattel has launched its latest addition to the Barbie range of dolls, the first with type 1 diabetes, which comes ...

In 2023, Varda sent a pharma manufacturing capsule into space to test a crystallisation process for HIV therapy ritonavir, a ...

Boehringer Ingelheim has raised hopes of a more patient-friendly option with the start of phase 2 testing of BI 1815368, ...

The three-stage framework below guides organisations through their agentic AI journey, ensuring effective ecosystem ...

Biogen has been trying to build up its R&D pipeline as it faces increased competition for its biggest-selling products like ...

Is chaos in US health policy creating new global opportunities? With major leadership and policy shake-ups the US healthcare ...